Accurate, visionary, and thought-provoking insight into issues that impact your business.
October 15, 2025 Lenders should connect smarter with digital precision and empathetic outreach for stronger recoveries and CX.
October 7, 2025 AI is making precision medicine surge: ~50% of FDA approvals by 2035. Build AI, data, and clinical infrastructure now or lose out.
October 6, 2025 The payer market is toast and if you have investments like platforms in there, it is time to bail.
October 3, 2025 New H-1B fees, stricter rules, and heavier compliance threaten a predictable pipeline of skilled offshore talent for BFS.
September 22, 2025 To unpack the how, HFS Research, in partnership with IBM, brought 17 top insurers to a New York boardroom.
September 15, 2025 HFS Research with DXC take a deeper look at how leading NA L&A insurers are navigating entrenched operational constraints.
September 4, 2025 Your screens could become a separate revenue generating engine through solutions like Wipro VisionEdge.
August 25, 2025 BBB upending healthcare, shift in demographics, and out of control increases should motivate employers to embrace new models.
August 11, 2025 Cheap delivery isn’t enough – enterprises need partners who can deliver smarter operating models and drive genuine transformation.
August 8, 2025 The BBB will disrupt US healthcare and put supplier consolidation on steriods unless they can reinvent their value proposition.
July 9, 2025 Tariffs exposed brittle delivery models, pushing bold enterprises to automate, adapt sourcing, and build resilience.
June 30, 2025 The experience of care has no impact to health outcomes or enterprises financials, yet billions are spent on it without merit.
If you don't have an account, Register here |
With the exception of our Horizons reports, most of our research is available for free on our website. Sign up for a free account and start realizing the power of insights now.
Our premium subscription gives enterprise clients access to our complete library of proprietary research, direct access to our industry analysts, and other benefits.
Contact us at [email protected] for more information on premium access.
